Protecting fertility in young cancer patients
Fertility Protection for Children, Adolescents and Young Adults
This study is trying to find ways to help young cancer patients keep their ability to have children after treatment by looking at what might affect their fertility.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Sex | All |
| Sponsor | University of Ulm Academic / other |
| Locations | 1 site (Ulm, Baden-Wurttemberg) |
| Trial ID | NCT06692868 on ClinicalTrials.gov |
What this trial studies
This observational study aims to enhance fertility preservation and long-term care for children, adolescents, and young adults undergoing cancer treatments or stem cell transplantation. It focuses on identifying factors that predict fertility issues post-treatment, addressing the concerns of patients and their families, and improving clinical practices related to fertility preservation. By creating a comprehensive database, the study seeks to document critical risk factors and improve the quality of care for this vulnerable population.
Who should consider this trial
Good fit: Ideal candidates include children, adolescents, and young adults diagnosed with cancer or undergoing stem cell transplantation before the age of 21.
Not a fit: Patients who are older than 21 or those without a cancer diagnosis or stem cell transplantation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to better fertility preservation strategies and support for young cancer patients, improving their quality of life.
How similar studies have performed: While fertility preservation in pediatric oncology has been addressed, this study's comprehensive approach to long-term follow-up and documentation is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Children, adolescents, young adults with a diagnosis of cancer before the age of 21 years or Children, adolescents, young adults undergoing SCT for a malignant or non-malignant condition before the age of 21 years treated at the Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Germany.
Where this trial is running
Ulm, Baden-Wurttemberg
- Universitätsklinikum Ulm, Klinik für Kinder- und Jugendmedizin, Sektion Pädiatrische Endokrinologie und Diabetologie — Ulm, Baden-Wurttemberg, Germany (Recruiting)
Study contacts
- Principal investigator: Christian Denzer, Prof. Dr. — Ulm University Medical Centre - Division of Paediatric Endocrinology and Diabetes
- Study coordinator: Christian Denzer, Prof. Dr.
- Email: christian.denzer@uniklinik-ulm.de
- Phone: +49 731 500 57056
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.